The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 29, 2022
Filed:
Jan. 29, 2018
Applicant:
Temple University of the Commonwealth System of Higher Education, Philadelphia, PA (US);
Inventors:
Kamel Khalili, Bala Cynwyd, PA (US);
Wenhui Hu, Cherry Hill, NJ (US);
Assignee:
Temple University—of the Commonwealth System of Higher Education, Philadelphia, PA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); C12N 15/11 (2006.01); A61K 48/00 (2006.01); A61K 9/00 (2006.01); A61K 35/12 (2015.01); A61K 45/06 (2006.01); C12N 7/00 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A61K 9/0034 (2013.01); A61K 35/12 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); A61K 48/005 (2013.01); C12N 7/00 (2013.01); C12N 9/22 (2013.01); C12N 15/111 (2013.01); C12N 2310/20 (2017.05); C12N 2320/30 (2013.01); C12N 2740/16063 (2013.01); C12Y 301/21 (2013.01);
Abstract
A method of treating a subject at risk for having a virus infection, by administering to the subject a prophylactically effective amount of a composition comprising a vector encoding a CRISPR-associated endonuclease and at least two guide RNAs, wherein the guide RNAs are complementary to two target sequences spanning from the 5'- to 3′-LTRs of the sequence in the virus, and preventing a retroviral infection.